nipah
viru
niv
came
limelight
recent
due
outbreak
kerala
india
niv
caus
sever
diseas
death
peopl
case
fatal
rate
public
health
concern
potenti
becom
global
pandem
lack
treatment
forc
contain
method
restrict
isol
surveil
r
blueprint
list
prioriti
diseas
indic
urgent
need
acceler
research
develop
address
niv
quest
druglik
niv
inhibitor
nvi
thorough
literatur
search
follow
systemat
data
curat
conduct
rigor
data
analysi
done
curat
nvi
priorit
druglik
compound
descriptor
nvi
comput
compar
analysi
perform
fda
approv
small
molecul
antivir
compound
evalu
pain
filter
studi
toxic
profil
simultan
compound
also
priorit
base
robust
assay
identifi
effort
lead
creation
wellcur
structur
knowledgebas
nvi
small
molecul
inhibitor
report
valu
inhibitor
nanomolar
rang
low
nm
order
priorit
inhibitor
perform
sever
test
appli
filter
identifi
druglik
nontox
compound
compound
pass
drulito
pain
filter
exhibit
druglik
properti
also
priorit
independ
screen
base
assay
robust
nvi
divers
structur
featur
offer
wide
spectrum
way
develop
druglik
molecul
report
knowledgebas
further
develop
nvi
platform
divers
set
nvi
priorit
base
combin
evid
strategi
platform
provis
submit
new
inhibitor
report
commun
enhanc
niv
inhibitor
landscap
nipah
infecti
negativesens
singlestrand
rna
viru
belong
genu
henipaviru
famili
paramyxovirida
pleomorph
envelop
viru
particl
size
rang
fruit
bat
thought
natur
reservoir
viru
also
abl
spread
human
speci
two
major
genet
lineag
viru
known
infect
human
ie
niv
malaysia
niv
niv
bangladesh
niv
b
first
outbreak
nipah
viru
infect
erupt
septemb
april
case
febril
enceph
suburb
ipoh
perak
southern
peninsular
malaysia
report
malaysian
ministri
health
moh
trace
back
crossspeci
transmiss
viru
pig
human
anoth
strain
viru
report
caus
outbreak
meherpur
bangladesh
sinc
outbreak
record
almost
annual
countri
surround
region
siliguri
india
outbreak
observ
mortal
rate
rang
although
direct
contact
infect
bat
contamin
could
caus
transmiss
viru
direct
humantohuman
transmiss
also
observ
case
healthcar
profession
rel
infect
patient
recent
viru
garner
attent
due
firstev
outbreak
southern
india
may
case
niv
report
kozhikod
kerala
subsequ
year
anoth
case
report
ernakulam
district
state
nipah
viru
caus
celltocel
fusion
host
thu
form
multinucl
cell
call
syncytia
allow
viru
spread
despit
absenc
viral
bud
greatli
influenc
pathogen
incub
period
viru
rang
day
http
wwwcdcgovvhfnipahpdffactsheetpdf
primarili
viru
infect
central
nervou
system
niv
b
strain
shown
signific
respiratori
involv
high
mutat
rate
human
human
transmiss
surviv
time
day
variou
environment
condit
lack
treatment
make
potenti
bioterror
agent
current
known
treatment
diseas
broadspectrum
antivir
ribavirin
shown
contradictori
result
even
optimist
one
significantli
caus
reduct
mortal
rate
favipiravir
purin
analogu
antivir
report
provid
protect
upto
day
syrian
hamster
model
challeng
lethal
dose
nipah
viru
recent
experiment
drug
remdesivir
demonstr
complet
protect
four
african
green
monkey
receiv
lethal
dose
nipah
viru
studi
plan
assess
efficaci
treatment
time
despit
lethal
pathogen
singl
drug
clinic
trial
viru
due
sever
challeng
discoveri
develop
nvi
along
lack
therapeut
intervent
pathogen
propens
viru
nipah
infect
enlist
amongst
list
prioriti
diseas
mention
variou
group
made
effort
year
identifi
nipah
viru
inhibitor
use
varieti
viral
assay
use
syncytia
format
titr
reduct
assay
identifi
nipah
viru
inhibitor
earlier
studi
report
nipah
inhibitor
base
screen
larg
librari
within
set
identifi
compound
inhibit
virusinduc
cytopath
effect
three
sulfonamid
compound
low
valu
report
screen
recent
bimolecular
multicellular
complement
assay
develop
use
identifi
potenti
antinipah
inhibitor
qualit
quantit
investig
format
syncytium
also
report
recent
human
monoclon
antibodi
crossneutr
niv
hev
cryoelectron
microscopi
follow
fusion
studi
demonstr
antibodi
bind
prefusionspecif
quaternari
epitop
conserv
niv
f
hev
f
glycoprotein
bind
prevent
membran
fusion
viral
entri
clearli
indic
import
hnv
prefus
f
conform
elicit
robust
immun
respons
despit
report
nipah
viru
inhibitor
systemat
evalu
report
compound
perform
antivir
inhibitor
databas
studi
exist
name
influenza
research
databas
ird
viru
pathogen
databas
analysi
resourc
vipr
enamin
librari
http
enaminenethitfindingfocusedlibrariesviewallantivirallibrari
etc
contain
limit
inform
focu
nipah
viru
one
focu
nipah
viru
inhibitor
either
scatter
dataset
curat
version
limit
evalu
antinipah
compound
start
point
drug
discoveri
develop
antinipah
inhibitor
toward
develop
combin
evid
base
strategi
systemat
evalu
nipah
viru
inhibitor
object
curat
antinipah
compound
use
crowdsourc
model
data
made
publicli
avail
http
vinodscariarnabiologyorgnipah
sinc
incept
project
may
two
prong
strategi
compris
priorit
nvi
base
robust
assay
use
identifi
ii
estim
sever
drug
like
paramet
nvi
drug
like
analysi
includ
divers
analysi
similar
fda
approv
compound
drug
repurpos
candid
report
antivir
identifi
new
scaffold
profil
base
pain
drulito
filter
comparison
zinc
lead
like
librari
data
curat
literatur
along
analys
made
avail
webbas
platform
also
allow
submiss
assess
new
molecul
report
nvi
pubm
http
wwwncbinlmnihgovpubm
googl
http
wwwgooglecom
two
main
sourc
consid
collect
inhibitor
show
activ
nipah
viru
research
paper
relev
studi
download
use
queri
nipah
keyword
abstracttitl
shortlist
time
curat
keyword
list
paper
consid
datamin
step
follow
score
system
wherein
paper
confirm
inform
regard
inhibitor
nipah
viru
abstract
assign
score
may
may
inform
regard
given
score
inform
peptid
use
inhibitor
assign
score
rest
relev
inform
given
score
paper
score
valu
consid
studi
manual
curat
creat
nipah
viru
inhibitor
knowledgebas
nvik
sheet
use
curat
organ
data
base
predefin
data
structur
shown
tabl
inhibitor
name
report
literatur
assay
type
order
ensur
data
qualiti
separ
team
curat
reperform
curat
independ
initi
team
error
mark
red
curat
sheet
mark
green
data
verifi
team
data
curat
qualiti
check
done
manual
data
store
nvikopen
resourc
sheet
serv
crowdsourc
platform
entri
tag
contributor
email
id
nipah
viru
inhibitor
knowledgebas
nvik
develop
use
open
sourc
lamp
linuxapachemysqlphp
server
technolog
also
use
php
html
javascript
ajax
css
webinterfac
provis
text
structur
complex
queri
base
search
option
brows
nvik
web
interfac
three
search
option
avail
name
simpl
search
queri
builder
structur
search
simpl
search
option
retriev
inform
use
textbas
queri
allselect
field
databas
user
select
display
search
record
overal
databas
contain
uniqu
field
shown
figur
extens
structur
search
interfac
also
avail
nvik
user
queri
use
smile
sdf
mol
format
addit
user
also
draw
compound
jsme
browser
may
search
nvik
data
nvi
brows
physicochem
properti
like
molecular
weight
xlogp
polar
surfac
area
psa
hydrogen
bond
donor
hbd
hydrogen
bond
acceptor
hba
number
rotat
bond
http
bioinfoimtechresinanshunipahphysicochemphp
databas
also
brows
major
field
shown
figur
custom
circo
http
circosca
one
earlier
studi
phytomolecul
mycobacteria
util
similar
approach
repres
relationship
among
physicochem
properti
nvi
custom
circo
inhibitor
defin
band
width
baselin
use
repres
cyclic
aliphat
compound
appropri
modif
appli
gener
histogram
file
view
compound
cluster
compound
network
diagram
cnd
made
use
cytoscap
http
wwwcytoscapeorg
present
nvik
entri
focu
studi
evalu
small
molecul
inhibitor
entri
rest
either
peptid
complet
inform
entri
uniqu
nipah
inhibitor
compound
one
assay
curat
literatur
valu
could
obtain
compound
structur
avail
inhibitor
valu
rang
nm
nm
entri
nm
nm
small
molecul
entri
compound
avail
drugbank
predict
antinipah
properti
nvik
compound
also
map
pubchemchemspid
id
wherev
possibl
overal
distribut
import
physicochem
properti
nvi
depict
figur
observ
compound
nvik
cyclic
natur
cluster
nvi
result
cluster
cluster
nvi
singleton
remain
cluster
nvi
nonsingleton
illustr
nvik
librari
chemic
divers
cluster
repres
compound
network
diagram
made
use
cytoscap
http
bioinfoimtechresinanshunipahcircosphp
cluster
also
report
circo
innermost
graph
figur
repres
near
neighbour
among
nvi
intrigu
observ
compound
differ
molecular
weight
rang
near
neighbour
exampl
gmol
near
neighbour
nuc
gmol
may
common
structur
featur
compound
respons
activ
niv
highlight
therefor
approach
use
identifi
potenti
pharmacophor
featur
import
contribut
antivir
properti
compound
comparison
nvi
done
fda
approv
compound
antivir
obtain
enamin
librari
enamin
librari
nucleosid
like
compound
http
enaminenethitfindingfocusedlibrariesviewallantivirallibrari
basi
physicochem
properti
suggest
lipinski
veber
observ
major
nvi
distribut
six
properti
similar
fda
approv
drug
also
case
enamin
compound
figur
drug
good
oral
avail
demonstr
topopsa
number
rotat
bond
total
nvi
similar
fda
approv
drugsf
eg
shown
structur
similar
four
fda
molecul
name
adenosin
neurotransmitt
vidarabin
activ
antivir
herp
vaccinia
varicella
zoster
viru
fludarabin
chemotherapi
drug
ademetionin
use
treatment
chronic
liver
diseas
addit
side
effect
predict
rat
toxic
report
drugbank
also
list
fda
approv
compound
similar
nvi
http
bioinfoimtechresinanshunipahfdaappphp
aid
priorit
nvi
potenti
safe
profil
oppos
one
report
side
effect
ccbync
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
order
priorit
druglik
nvi
drulito
use
screen
compound
base
eight
filter
name
lipinski
rule
mddrlike
rule
veber
rule
ghose
filter
bbb
rule
like
rule
weight
unweight
quantit
estim
druglik
seen
figur
two
compound
pass
filter
cmc
filter
order
priorit
nvi
studi
perform
independ
evalu
compound
base
robust
assay
use
identifi
base
analysi
prioritis
nvi
analysi
nvi
also
indic
physicochem
descriptor
valu
closer
exist
drug
like
fda
approv
compound
analysi
fda
approv
compound
sever
physicochem
paramet
name
molecular
weight
number
hydrogen
bond
donor
number
hydrogen
bond
acceptor
number
rotat
bond
xlogp
topolog
polar
surfac
area
reveal
priorit
nvi
drug
like
featur
seen
tabl
exhibit
better
activ
among
three
consider
overlap
physicochem
properti
fda
approv
drug
scope
current
studi
perform
systemat
evalu
physicochem
properti
nvi
respect
fda
approv
drug
antivir
librari
understand
divers
chemic
scaffold
correl
comput
properti
experiment
report
bioactiv
dataset
propos
list
priorit
candid
order
simplifi
data
access
enhanc
data
librari
webbas
platform
design
report
new
compound
analysi
priorit
potenti
nvi
nvik
freeli
access
http
bioinfoimtechresinanshunipah
access
featur
nvik
optimum
level
javascript
java
runtim
environ
jre
plugin
must
enabl
nk
kt
compil
data
literatur
nk
kt
prp
au
curat
data
updat
field
wherev
data
incomplet
nk
prp
curat
chemic
structur
kt
kk
rk
develop
databas
webbas
tool
interfac
nvik
input
nk
ab
nk
perform
compound
analysi
ts
nk
plot
visual
plot
circo
cnd
ec
perform
assay
robust
analysi
rank
nk
kt
prp
au
ab
draft
manuscript
vs
ab
conceiv
design
project
refin
manuscript
vs
ab
defin
sop
data
collect
also
data
structur
manuscript
read
approv
author
